HAIKOU CITY, China, March 1 China PharmaHoldings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops,manufactures, and markets specialty pharmaceutical products in China, todayannounced that it will participate in the following conferences:
For further details, please contact your respective institutional salesrepresentative.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company withrapidly growing profit that develops, manufactures, and markets treatments fora wide range of high incidence and high mortality conditions in China,including cardiovascular, CNS, infectious, and digestive diseases. TheCompany's cost-effective, high margin business model is driven by marketdemand and supported by eight scalable GMP-certified product lines coveringthe major dosage forms. In addition, the Company has a broad and expandingdistribution network across 30 provinces, municipalities and autonomousregions. The Company is registered in Delaware, USA. Hainan Helpson Medical &Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province,China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For moreinformation about China Pharma Holdings, Inc., please visithttp://www.chinapharmaholdings.com .-- Rodman & Renshaw Annual China Investment Conference, to be held March 7-9, 2010 at the Regent hotel in Beijing, China. Management is scheduled to present at 4:05 pm local time on Monday, March 8, and meet with institutional investors throughout the conference. -- Cowen & Company's 30th Annual Health Care Conference, to be held March 8-11 at the Marriott Copley Place in Boston. Management is scheduled to present at 8:45 am local time on Wednesday, March 10, and meet with institutional investors throughout the conference. -- Roth 22nd Annual OC Growth Stock Conference, to be held March 15-17, 2010 at the Ritz Carlton hotel in Dana Point, CA. Management is scheduled to present at 9:00 am local time on Tuesday, March 16, and meet with institutional investors throughout the conference.
SOURCE China Pharma Holdings, Inc.